George Notas

Prof. Dr. George Notas

Emergency Medicine, University of Crete, Heraklion, Greece
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2003 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
MKMarilena Kampa
Marilena Kampa
VAVassilia-Ismini Alexaki
Vassilia-Ismini Alexaki
George NotasGeorge Notas
George Notas
ANArtemissia-Phoebe Nifli
Artemissia-Phoebe Nifli
ANAnastassia Nistikaki
Anastassia Nistikaki
ECElias Castanas
Elias Castanas
The oncoprotective role of food-derived polyphenol antioxidants has been described but the implicated mechanisms are not yet clear. In addition to polyphenols, phenolic acids, found at high concentrations in a number of plants, possess antioxidant action. The main phenolic acids found in foods are derivatives of 4-hydroxybenzoic acid and 4-hydroxycinnamic acid. This work concentrates on the antiproliferative action of caffeic acid, syringic acid, sinapic acid, protocatechuic acid, ferulic acid and 3,4-dihydroxy-phenylacetic acid (PAA) on T47D human breast cancer cells, testing their antioxidant activity and a number of possible mechanisms involved (interaction with membrane and intracellular receptors, nitric oxide production). The tested compounds showed a time-dependent and dose-dependent inhibitory effect on cell growth with the following potency: caffeic acid > ferulic acid = protocatechuic acid = PAA > sinapic acid = syringic acid. Caffeic acid and PAA were chosen for further analysis. The antioxidative activity of these phenolic acids in T47D cells does not coincide with their inhibitory effect on tumoral proliferation. No interaction was found with steroid and adrenergic receptors. PAA induced an inhibition of nitric oxide synthase, while caffeic acid competes for binding and results in an inhibition of aryl hydrocarbon receptor-induced CYP1A1 enzyme. Both agents induce apoptosis via the Fas/FasL system. Phenolic acids exert a direct antiproliferative action, evident at low concentrations, comparable with those found in biological fluids after ingestion of foods rich in phenolic acids. Furthermore, the direct interaction with the aryl hydrocarbon receptor, the nitric oxide synthase inhibition and their pro-apoptotic effect provide some insights into their biological mode of action.

6 June 2000 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ADAthina Damianaki
Athina Damianaki
EBEfstathia Bakogeorgou
Efstathia Bakogeorgou
MKMarilenna Kampa
Marilenna Kampa
George NotasGeorge Notas
George Notas
AHAnastassia Hatzoglou
Anastassia Hatzoglou
ECElias Castanas
Elias Castanas

22 September 2015 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
VPVasiliki Pelekanou
Vasiliki Pelekanou
MKMarilena Kampa
Marilena Kampa
FKFoteini Kiagiadaki
Foteini Kiagiadaki
ADAlexandra Deli
Alexandra Deli
PTPanayiotis Theodoropoulos
Panayiotis Theodoropoulos
George NotasGeorge Notas
George Notas
Estrogens are known modulators of monocyte/macrophage functions; however, the underlying mechanism has not been clearly defined. Recently, a number of estrogen receptor molecules and splice variants were identified that exert different and sometimes opposing actions. We assessed the expression of estrogen receptors and explored their role in mediating estrogenic anti-inflammatory effects on human primary monocytes. We report that the only estrogen receptors expressed are estrogen receptor-α 36-kDa splice variant and G-protein coupled receptor 30/G-protein estrogen receptor 1, in a sex-independent manner. 17-β-Estradiol inhibits the LPS-induced IL-6 inflammatory response, resulting in inhibition of NF-κB transcriptional activity. This is achieved via a direct physical interaction of ligand-activated estrogen receptor-α 36-kDa splice variant with the p65 component of NF-κB in the nucleus. G-protein coupled receptor 30/G-protein estrogen receptor 1, which also physically interacts with estrogen receptor-α 36-kDa splice variant, acts a coregulator in this process, because its inhibition blocks the effect of estrogens on IL-6 expression. However, its activation does not mimic the effect of estrogens, on neither IL-6 nor NF-κB activity. Finally, we show that the estrogen receptor profile observed in monocytes is not modified during their differentiation to macrophages or dendritic cells in vitro and is shared in vivo by macrophages present in atherosclerotic plaques. These results position estrogen receptor-α 36-kDa splice variant and G-protein coupled receptor 30 as important players and potential therapeutic targets in monocyte/macrophage-dependent inflammatory processes.

1 July 2000 in Nutrition and Cancer
Verified
Journal Article
Closed access
MKMarilenna Kampa
Marilenna Kampa
AHAnastassia Hatzoglou
Anastassia Hatzoglou
George NotasGeorge Notas
George Notas
ADAthina Damianaki
Athina Damianaki
EBEfstathia Bakogeorgou
Efstathia Bakogeorgou
ECElias Castanas
Elias Castanas
The effect of different wine antioxidant polyphenols (catechin, epicatechin, quercetin, and resveratrol) on the growth of three prostate cancer cell lines (LNCaP, PC3, and DU145) was investigated. A dose- and time-dependent inhibition of cell growth by polyphenols was found at nanomolar concentrations. The proliferation of LNCaP and PC3 cells was preferentially inhibited by flavonoids (catechin, epicatechin, and quercetin), whereas resveratrol was the most potent inhibitor of DU145 cell growth. Possible mechanisms of action were investigated: 1) The competition of polyphenols for androgen binding in LNCaP cells revealed significant interaction only in the case of high concentrations of quercetin, at least at five orders of magnitude higher than the concentrations needed for cell growth inhibition. All other phenols showed low interactions. 2) Oxygen species production after mitogen stimulation and H²O²2 sensitivity of these cell lines did not correlate with the observed antiproliferative effects, ruling o...

1 January 2009 in Clinical Immunology
Verified
Journal Article
Closed access
George NotasGeorge Notas
George Notas
TKTatiana Kisseleva
Tatiana Kisseleva
DBDavid Allen Brenner
David Allen Brenner

6 June 2007
Verified
Book Chapter
Closed access
PDF file
MKM. Kampa
M. Kampa
ANArtemissia-Phoebe Nifli
Artemissia-Phoebe Nifli
George NotasGeorge Notas
George Notas
ECElias Castanas
Elias Castanas